Baird analyst Mircea Dobre upgrades REV Group (NYSE:REVG) from Neutral to Outperform and announces $16 price target.
BAMF Health And GE HealthCare Collaborate To Enable Sustainable And Scalable Solutions For Growth In Theranostics; Expanding The Reach Of Care For Cancer And Other Disease States
Long-term relationship will focus on the potential for new advancements to expand patient and clinician access and transform the approach to discovery, diagnosis, and treatment of cancer and other disease states.As
